The agreements aim to strengthen medicine quality, patient safety and pharmaceutical research in India
Coverage has been significantly strengthened across key therapeutic categories, including anti-tubercular, anti-diabetic and anti-cancer medicines, as well as iron supplements, thereby ensuring more comprehensive standardisation of medicines used under various National Health Programmes
Indian Pharmacopoeia is now recognised in 19 countries, reflecting growing international confidence in India’s regulatory and scientific capabilities
India has been declared ‘functional’ against all the core regulatory functions of the WHO Global Benchmarking Tool Version VI
These digital initiatives are expected to enhance the accessibility and efficiency of drug safety monitoring and standards compliance
The Indian Pharmacopoeia Commission (IPC) has added 23 new impurities standards and 7 new Indian Pharmacopoeial Reference standards
The aim is to support Pharmacovigilance programme across the countries in the region
Subscribe To Our Newsletter & Stay Updated
